|
| 36849657 | Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. | Nat Genet | 2023 |
| 36999648 | BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme. | Histopathology | 2023 |
| 36849657 | Multiomic analysis of homologous recombination-deficient end-stage high-grade serous ovarian cancer. | Nat Genet | 2023 |
| 36999648 | BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme. | Histopathology | 2023 |
| 35263119 | TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members. | J Clin Oncol | 2022 |
| 35400525 | Germline BRCA variants, lifestyle and ovarian cancer survival. | Gynecol Oncol | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 35263119 | TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members. | J Clin Oncol | 2022 |
| 35400525 | Germline BRCA variants, lifestyle and ovarian cancer survival. | Gynecol Oncol | 2022 |
| 36456881 | The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancer. | Nat Genet | 2022 |
| 33664264 | Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. | Nat Commun | 2021 |
| 33664264 | Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. | Nat Commun | 2021 |
| 30894541 | Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. | Nat Commun | 2019 |
| 30894541 | Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer. | Nat Commun | 2019 |
| 29061645 | Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer. | Clin Cancer Res | 2018 |
| 30266954 | Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. | Nat Commun | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 29061645 | Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer. | Clin Cancer Res | 2018 |
| 29807697 | Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance. | Gynecol Oncol | 2018 |
| 29807697 | Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance. | Gynecol Oncol | 2018 |
| 30062862 | Association of p16 expression with prognosis varies across ovarian carcinoma histotypes: an Ovarian Tumor Tissue Analysis consortium study. | J Pathol Clin Res | 2018 |
| 30266954 | Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma. | Nat Commun | 2018 |
| 28430777 | Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". | PLoS Med | 2017 |
| 35172485 | Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma. | JCO Precis Oncol | 2017 |
| 28430777 | Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". | PLoS Med | 2017 |
| 35172485 | Circulating Tumor DNA Analysis and Functional Imaging Provide Complementary Approaches for Comprehensive Disease Monitoring in Metastatic Melanoma. | JCO Precis Oncol | 2017 |
| 26823519 | PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. | J Natl Cancer Inst | 2016 |
| 26823519 | PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. | J Natl Cancer Inst | 2016 |
| 27444035 | Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. | Gynecol Oncol | 2016 |
| 27617737 | A community-based model of rapid autopsy in end-stage cancer patients. | Nat Biotechnol | 2016 |
| 27798111 | The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer. | Hum Mol Genet | 2016 |
| 28027312 | The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". | PLoS Med | 2016 |
| 27617737 | A community-based model of rapid autopsy in end-stage cancer patients. | Nat Biotechnol | 2016 |
| 28027312 | The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE". | PLoS Med | 2016 |
| 27798111 | The RING finger domain E3 ubiquitin ligases BRCA1 and the RNF20/RNF40 complex in global loss of the chromatin mark histone H2B monoubiquitination (H2Bub1) in cell line models and primary high-grade serous ovarian cancer. | Hum Mol Genet | 2016 |
| 27444035 | Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. | Gynecol Oncol | 2016 |
| 24824132 | Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS). | Eur J Hum Genet | 2015 |
| 25398451 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. | Clin Cancer Res | 2015 |
| 25678442 | Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. | Fam Cancer | 2015 |
| 26017449 | Whole-genome characterization of chemoresistant ovarian cancer. | Nature | 2015 |
| 26315354 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. | J Natl Cancer Inst | 2015 |
| 26261251 | Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. | J Clin Oncol | 2015 |
| 26503049 | Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer. | Nature | 2015 |
| 24824132 | Connecting patients, researchers and clinical genetics services: the experiences of participants in the Australian Ovarian Cancer Study (AOCS). | Eur J Hum Genet | 2015 |
| 26503049 | Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer. | Nature | 2015 |
| 26315354 | Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. | J Natl Cancer Inst | 2015 |
| 26261251 | Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. | J Clin Oncol | 2015 |
| 26017449 | Whole-genome characterization of chemoresistant ovarian cancer. | Nature | 2015 |
| 25678442 | Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features. | Fam Cancer | 2015 |
| 25398451 | Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. | Clin Cancer Res | 2015 |